Hi there. Orkambi user for a few years now. Two copies of Delta F508. Correct me if I am wrong, but this latest Trikafta drug does not improve the level of corrected CTFR over that of Orkambi, correct? Its basically just coverage of more mutations and not a notch forward as far as percentage of corrected CTFR. Also, does any know anything about the mRNA therapies that are in the pipeline that are being advertised as correcting ALL or most of the CTFR within the lungs? Is that just the theory and/or marketing talk? Thanks.